Shopping Cart 0
Cart Subtotal
USD 0

Pharmaceuticals in North America

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 350

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 700

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 1050
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase

Details

Pharmaceuticals in North America

Summary

Pharmaceuticals in North America industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis

Essential resource for top-line data and analysis covering the North America pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Key highlights

- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.

- The North American pharmaceuticals market had total revenues of USD 444.3bn in 2017, representing a compound annual growth rate (CAGR) of 7.6% between 2013 and 2017.

- Obesity is an increasingly bigger problem in North America which means a large demand for medication for its co-morbidities-heart disease and diabetes.

- The US is by far the largest market in the region, and maintains good growth consistently despite its developed nature due to the very strong private health sector.

Scope

- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in North America

- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in North America

- Leading company profiles reveal details of key pharmaceuticals market players' global operations and financial performance

- Add weight to presentations and pitches by understanding the future growth prospects of the North America pharmaceuticals market with five year forecasts

Reasons to buy

- What was the size of the North America pharmaceuticals market by value in 2017?

- What will be the size of the North America pharmaceuticals market in 2022?

- What factors are affecting the strength of competition in the North America pharmaceuticals market?

- How has the market performed over the last five years?

- Who are the top competitiors in North America's pharmaceuticals market?

READ MORE

Table Of Content

Scope

Table of Contents

Executive Summary 2

Market value 2

Market value forecast 2

Geography segmentation 2

Market share 2

Market rivalry 2

Market Overview 7

Market definition 7

Market analysis 7

Market Data 9

Market value 9

Market Segmentation 10

Geography segmentation 10

Market share 11

Market Outlook 12

Market value forecast 12

Five Forces Analysis 13

Summary 13

Buyer power 14

Supplier power 16

New entrants 18

Threat of substitutes 20

Degree of rivalry 21

Leading Companies 23

AstraZeneca PLC 23

Johnson & Johnson 26

Merck & Co., Inc. 29

Pfizer Inc. 32

Methodology 36

Industry associations 37

Related MarketLine research 37

Appendix 38

About MarketLine 38


List Of Figure

List of Figures

Figure 1: North America pharmaceuticals market value: USD billion, 2013-17

Figure 2: North America pharmaceuticals market geography segmentation: % share, by value, 2017

Figure 3: North America pharmaceuticals market share: % share, by value, 2017

Figure 4: North America pharmaceuticals market value forecast: USD billion, 2017-22

Figure 5: Forces driving competition in the pharmaceuticals market in North America, 2017

Figure 6: Drivers of buyer power in the pharmaceuticals market in North America, 2017

Figure 7: Drivers of supplier power in the pharmaceuticals market in North America, 2017

Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in North America, 2017

Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in North America, 2017

Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in North America, 2017

Figure 11: AstraZeneca PLC: revenues & profitability

Figure 12: AstraZeneca PLC: assets & liabilities

Figure 13: Johnson & Johnson: revenues & profitability

Figure 14: Johnson & Johnson: assets & liabilities

Figure 15: Merck & Co., Inc.: revenues & profitability

Figure 16: Merck & Co., Inc.: assets & liabilities

Figure 17: Pfizer Inc.: revenues & profitability

Figure 18: Pfizer Inc.: assets & liabilities


List Of Table

List of Tables

Table 1: North America pharmaceuticals market value: USD billion, 2013-17

Table 2: North America pharmaceuticals market geography segmentation: USD billion, 2017

Table 3: North America pharmaceuticals market share: % share, by value, 2017

Table 4: North America pharmaceuticals market value forecast: USD billion, 2017-22

Table 5: AstraZeneca PLC: key facts

Table 6: AstraZeneca PLC: key financials (USD )

Table 7: AstraZeneca PLC: key financial ratios

Table 8: Johnson & Johnson: key facts

Table 9: Johnson & Johnson: key financials (USD )

Table 10: Johnson & Johnson: key financial ratios

Table 11: Merck & Co., Inc.: key facts

Table 12: Merck & Co., Inc.: key financials (USD )

Table 13: Merck & Co., Inc.: key financial ratios

Table 14: Pfizer Inc.: key facts

Table 15: Pfizer Inc.: key financials (USD )

Table 16: Pfizer Inc.: key financial ratios

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License: 
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:  
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com